<section class="py-20 bg-[#fafdfa]">
    <div class="container">
        <div class="max-w-[516px] md:max-w-[696px] xl:max-w-[856px] bg-white mx-auto px-6 pt-10 pb-6 shadow-2xl rounded-2xl">
            <h1 class ="text-2xl sm:text-[34px] mb-2 sm:leading-10 tracking-[.05px] font-bold">RECOGNIZED BY LEADING European Media Outlet</h1>
            <div class="my-[14px] pt-6">
                <img src="./assets/images/inpost-11.png" alt="invest post">
            </div>
            <div class="[&>p]:my-[14px] [&>p]:text-sm [&>p]:tracking-[.05px] [&_span]:text-lg [&_span]:!leading-5">
                <p>&nbsp;</p>
                <p><strong><span>CancerVax was honored to be featured by Labiotech</span></strong>, the leading online media publication for the biotech industry in Europe. &nbsp;As the most visited biotech website in Europe and a trusted source of information for many professionals, it is exciting that <span><strong>CancerVax’s important work was included</strong></span> in a recent article.&nbsp;</p>
                <p>Labiotechs is widely read and respected by<strong><span>&nbsp;biotech CEOs and medical thought leaders from all over the world.</span></strong></p>
                <p><strong><span>This attention is important and provides opportunities for CancerVax&nbsp;</span></strong>to show the progress it has made.</p>
                <p>This Labiotech article discusses the complexities and challenges of <strong><span>developing a drug for Ewing sarcoma</span></strong>, a deadly form of children’s cancer that begins in leg bones, spine and pelvis.</p>
                <p><strong><span>CancerVax working with UCLA to develop an immunotherapy drug</span></strong> that is aimed at targeting and killing the Ewing sarcoma tumor.&nbsp;</p>
                <p class="text-center"><span><strong>We invite you to help us in the fight against cancer by investing in CancerVax.</strong></span></p>
            </div>
            <div class="flex justify-center items-center"><a href="https://join.cancervax.com/act" target="_blank" rel="noopener noreferrer"><img src="https://d2j6gq8tvnyhoe.cloudfront.net/f50c1cb1-2916-4e4d-a9bf-e4deb3e9f2d7.png"></a></div>
            <div>
                <p class="text-sm my-[14px] text-center tracking-[.05px]">For more information about CancerVax, please visit <a href="https://www.cancervax.com/" class="underline text-purple-900" target="_blank" rel="noopener noreferrer">https://www.cancervax.com/</a></p>
                <h5 class="text-xs leading-5 font-normal text-center tracking-[.05px]">This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.</h5>
            </div>
        </div>
    </div>
</section>